Food Lipids: Chemistry, Nutrition, and Biotechnology

fatty acid margarine on serum lipids and lipoproteins in healthy men. J. Lipid Res. 34:
1 (1993).
67. J. L. Zevbergen, U. M. T. Houtsmüller, and J. J. Gottenbos. Linoleic acid requirement
of rats fed trans fatty acids. Lipids 23:178 (1988).
68. H. Heckers, M. Korner, T. W. L. Tuschen, and F. W. Melcher. Occurrence of individual
trans-isomeric fatty acids in human myocardium, jejunum and aorta in relation to degrees
of atherosclerosis. Artherosclerosis 28:389 (1977).
69. A. Aro, A. F. M. Kardinaal, I. Salminen, J. D. Kark, R. A. Riemersma, M. Delgado-
Rodriguez, J. Gomez-Arcena, J. K. Huttienen, L. Kohlmeier, B. C. Martin, J. M. Martin-Moreno,
V. P. Niagaev, J. Ringstad, M. Thamm, P. van’t Veer, and F. J. Kok.
Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine
countries: The Euramic study. Lancet 345:273 (1995).
70. U. M. T. Houtsmüller. Biochemical aspects of fatty acids with trans double bonds.
Fette. Seifen. Anstrichm. 80:162 (1978).
71. F. R. Senti (ed.). Health aspects of dietary trans fatty acids. LSRO, Bethesda, MD
(1985).
72. British Nutrition Foundation. Trans fatty acids. London, 1987.
73. P. M. Kris Etherton (ed.). Trans fatty acids and coronary heart disease risk. Am. J.
Clin. Nutr. 62:655S (1995).
74. British Nutrition Foundation Task Force. Trans fatty acids. London, 1995.
75. D. Kritchevsky. Trans fatty acids and cardiovascular risk. Prostaglandins, Leukotrienes,
Essential Fatty Acids 57:399 (1997).
76. A. H. Lichtenstein. Trans fatty acids and cardiovascular disease risk. Curr. Opin. Lipidol.
11:37 (2000).
77. J. E. Hunter and T. H. Applewhite. Reassessment of trans fatty acid availability in the
U.S. diet. Am. J. Clin. Nutr. 54:363 (1991).
78. Health United States, 1994. DHHS Publ. No. (PH5 95-1232). Hyattsville, MD, Natl.
Center for Health Statistics (1995).
79. K. S. McCully. Vascular pathology of homocysteinemia: Implications for the pathogenesis
of atherosclerosis. Am. J. Pathol. 56:111 (1969).
80. M. R. Malinow. Plasma homocyst(e)ine: A risk factor for arterial disease. J. Nutr. 126:
1238S (1996).
81. M. R. Nehler, L. M. Taylor, Jr., and J. M. Porter. Homocysteinemia as a risk factor for
atherosclerosis: A review. Cardiovasc. Pathol. 6:1 (1997).
82. G. Alfthan, A. Aro, and K. F. Gey. Plasma homocysteine and cardiovascular disease
mortality. Lancet 349:397 (1997).
83. A. E. Evans, J. B. Ruidavets, E. E. McCrum, J. P. Cambou, R. McClear, P. Douste-
Blazy, D. McMaster, A. Bingham, C. C. Patterson, J. L. Richard, J. M. Mathewson,
and F. Cambien. Autres pays, autres cours? Dietary patterns, risk factors and ischaemic
heart disease in Belfast and Toulouse. Q. J. Med. 88:469 (1995).
84. M. Kristenson, B. Zieden, Z. Kucinskienë, L. S. Elinder, B. Bergdall, B. Elwig, A.
Abaravicius, L. Razinkovienë, H. Calkauskas, and A. G. Olsson. Antioxidant state and
mortality from heart disease in Lithuanian and Swedish men: Concomitant cross sectional
study of men aged 50. Br. Med. J. 314:629 (1997).
85. D. B. Shestov, A. D. Deev, A. N. Klimov, C. E. Davis, and H. A. Tyroler. Increased
risk of coronary heart disease: Death in men with low total and low-density lipoprotein
in the Russian lipid research clinics prevalence follow-up study. Circulation 88:846
(1993).
86. P. Saikku, M. Leinonen, K. Matilla, M. R. Ekman, M. S. Nieminen, P. H. Mäkelä, J.
K. Huttunen, and V. Valtonen. Serological evidence of an association of a novel chlamydia,
TWAR, with chronic coronary heart disease and acute myocardial infarction.
Lancet 2:983 (1988).
Copyright 2002 by Marcel Dekker, Inc. All Rights Reserved.